Unlocking Q1 Potential of Collegium Pharmaceutical (COLL): Exploring Wall Street Estimates for Key Metrics [Yahoo! Finance]
Amneal Pharmaceuticals (AMRX) Q1 Earnings and Revenues Surpass Estimates [Yahoo! Finance]
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Collegium (COLL) to Report Q1 Earnings: Here's What to Expect [Yahoo! Finance]
Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ER [Yahoo! Finance]